{"created":"2023-06-19T07:25:22.181237+00:00","id":13130,"links":{},"metadata":{"_buckets":{"deposit":"f1d7f506-3647-4bd7-820d-6d4b1eb46f74"},"_deposit":{"created_by":39,"id":"13130","owners":[39],"pid":{"revision_id":0,"type":"depid","value":"13130"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00013130","sets":["212:361:364"]},"author_link":["18571","18570","18569"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-05-31","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{},{"bibliographic_title":"Investigational new drugs","bibliographic_titleLang":"en"}]}]},"item_3_text_4":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_text_value":"https://doi.org/10.1007/s10637-018-0612-y"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Breakthrough therapy designation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Cancer","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Drug lag","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"External collaboration","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Japan","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Orphan drug","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States."},{"subitem_title":"The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States.","subitem_title_language":"en"}]},"item_type_id":"3","owner":"39","path":["364"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-06-14"},"publish_date":"2018-06-14","publish_status":"0","recid":"13130","relation_version_is_last":true,"title":["The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States."],"weko_creator_id":"39","weko_shared_id":-1},"updated":"2023-06-19T08:58:54.627810+00:00"}